Back
ESC2025 Premium Access

Gene-specific risk models in genetic dilated cardiomyopathy for implantable cardioverter defibrillator decisions: a critical perspective on limitations and applicability

Session: Risk prediction and management of ventricular arrhythmias in non-ischaemic cardiomyopathies
Topic: Risk Factors and Risk Assessment
Speaker: Doctor A. Beblo (Berlin, DE)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Amelie Beblo

Charite University Hospital, Berlin (Germany)
1 presentation
0 follower

6 more presentations in this session

Myocardial fibrosis predicts sudden cardiac death in patients with hypertrophic cardiomyopathy after cardiac electronic device implantation: a retrospective study

Speaker: Doctor X. Lian (Beijing, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

Late gadolinium enhancement and ventricular arrhythmias in patients with dilated cardiomyopathy: a systematic review and meta-analysis

Speaker: Ms S. Mahmud (Stony Brook, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Cohort analysis of variants in the RBM20 gene. Is there a profile for electrocardiographic phenotype, arrhythmogenic features and outcomes?

Speaker: Doctor M. Pagotti (Sao Paulo, BR)

Access
Abstract
Slides
Like
Thumbnail

Genetic defects in young out-of-hospital cardiac arrest (OHCA) patients in our city: the GenetiCA study

Speaker: Doctor E. Baldi (Pavia, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Myocarditis complicated by ventricular tachycardia: prevalence, outcomes and acute ablation results

Speaker: Associate Professor E. Leshem (Hadera, IL)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Risk prediction and management of ventricular arrhythmias in non-ischaemic cardiomyopathies

Speakers: Doctor A. Beblo, Doctor X. Lian, Ms S. Mahmud, Doctor M. Pagotti, Doctor E. Baldi...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources